Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty

References

• Kim YH, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 2002;84(4):566–70.
   PubMedGoogle Scholar
• Kim YH, Oh SH, Kim JS. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 2003;85(5):661
   PubMedGoogle Scholar
• Migita K, Bito S, Nakamura M, Miyata S, Saito M, Kakizaki H, et al. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study. Arthritis Res Ther. 2014;16(4):R154.
   PubMed Web of Science ®Google Scholar
• Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop Relat Res. 2000;375:168–74.
   Google Scholar
• JCS Joint Working G. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J. 2011;75:1258–81.
   PubMed Web of Science ®Google Scholar
• Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, et al. Asian venous thromboembolism guidelines: prevention of venous thromboembolism. Int Angiol. 2012;31:501–16.
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–52.
   PubMed Web of Science ®Google Scholar
• Motohashi M, Adachi A, Takigami K, Yasuda K, Inoue M, Sasaki S, et al. Deep vein thrombosis in orthopedic surgery of the lower extremities. Ann Vasc Dis. 2012;5(3):328–33.
   PubMedGoogle Scholar
• Tanaka S, Nishigami K, Taniguchi N, Matsuo H, Hirai T, Kaneda S, et al. Members of the subcommittee for preparing guidelines for ultrasound diagnosis of venous thrombosis of lower extremities of the terminology and diagnostic criteria committee, Japan society of ultrasonics in medicine. Criteria for ultrasound diagnosis of deep venous thrombosis of lower extremities. J Med Ultrason. 2008;35:33–6.
   PubMedGoogle Scholar
• Elliott CG, Suchyta M, Rose SC, Talbot S, Ford C, Raskob G, et al. Duplex ultrasonography for the detection of deep vein thrombi after total hip or knee arthroplasty. Angiology. 1993;44(1):26–33.
   PubMed Web of Science ®Google Scholar
• Mayer A, Schuster P, Fink B. A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery. Arch Orthop Trauma Surg. 2017;137(6):797–803.
   PubMed Web of Science ®Google Scholar
• Feng W, Wu K, Liu Z, Kong G, Deng Z, Chen S, et al. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis. Thromb Res. 2015;136(6):1133–44.
   PubMed Web of Science ®Google Scholar
• Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF, et al. Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: a meta-analysis. J Arthroplasty. 2017;32(2):645–52.
   PubMed Web of Science ®Google Scholar
• Hokusai VTE, Investigators BHR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369(15):1406.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Wang YQ, Wang C, Oh D, Yin WH, Kimura T, et al. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost. 2015;13(9):1606–14.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799–808.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Nishikawa M, Komuro I, Kitajima I, Uetsuka Y, Yamagami T, et al. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). Circ J. 2015;79(6):1230.
   PubMed Web of Science ®Google Scholar
• Bartlett M, Mauck KF, Bierle DM, Saadiq RA, Daniels PR. Updates in venous thromboembolism management: evidence published in 2016. Hosp Pract. 2017;45(3):65–9.
   PubMedGoogle Scholar
• Ieko M, Tarumi T, Takeda M, Naito S, Nakabayashi T, Koike T. Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis. J Thromb Haemost. 2004;2(4):612–8.
   PubMed Web of Science ®Google Scholar
• Ma G, Zhang R, Wu X, Wang D, Ying K. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials. Thromb Res. 2015;135(5):816–22.
   PubMed Web of Science ®Google Scholar